Releases › HCPCS Level II July 2023

HCPCS Level II July 2023

Effective 2023-07-01 to 2023-09-30. 7,894 codes in the release.

63added

3revised

9removed

Codes added 63

Code	Description
C9150	Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
C9151	Injection, pegcetacoplan, 1 mg
C9784	Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components
C9785	Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components
C9786	Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report
C9787	Gastric electrophysiology mapping with simultaneous patient symptom profiling
J0137	Injection, acetaminophen (hikma) not therapeutically equivalent to j0131, 10 mg
J0174	Injection, lecanemab-irmb, 1 mg
J0206	Injection, allopurinol sodium, 1 mg
J0216	Injection, alfentanil hydrochloride, 500 micrograms
J0457	Injection, aztreonam, 100 mg
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg
J0736	Injection, clindamycin phosphate, 300 mg
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
J1440	Fecal microbiota, live - jslm, 1 ml
J1576	Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1805	Injection, esmolol hydrochloride, 10 mg
J1806	Injection, esmolol hydrochloride (wg critical care) not therapeutically equivalent to j1805, 10 mg
J1811	Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
J1812	Insulin (fiasp), per 5 units
J1813	Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
J1814	Insulin (lyumjev), per 5 units
J1836	Injection, metronidazole, 10 mg
J1920	Injection, labetalol hydrochloride, 5 mg
J1921	Injection, labetalol hydrochloride (hikma) not therapeutically equivalent to j1820, 5 mg
J1941	Injection, furosemide (furoscix), 20 mg
J1961	Injection, lenacapavir, 1 mg
J2249	Injection, remimazolam, 1 mg
J2305	Injection, nitroglycerin, 5 mg
J2329	Injection, ublituximab-xiiy, 1mg
J2371	Injection, phenylephrine hydrochloride, 20 micrograms
J2372	Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
J2427	Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
J2561	Injection, phenobarbital sodium (sezaby), 1 mg
J2598	Injection, vasopressin, 1 unit
J2599	Injection, vasopressin (american regent) not therapeutically equivalent to j2598, 1 unit
J2806	Injection, sincalide (maia) not therapeutically equivalent to j2805, 5 micrograms
J7213	Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
J9029	Injection, nadofaragene firadenovec-vncg, per therapeutic dose
J9056	Injection, bendamustine hydrochloride (vivimusta), 1 mg
J9058	Injection, bendamustine hydrochloride (apotex), 1 mg
J9059	Injection, bendamustine hydrochloride (baxter), 1 mg
J9063	Injection, mirvetuximab soravtansine-gynx, 1 mg
J9259	Injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg
J9322	Injection, pemetrexed (bluepoint) not therapeutically equivalent to j9305, 10 mg
J9323	Injection, pemetrexed ditromethamine, 10 mg
J9347	Injection, tremelimumab-actl, 1 mg
J9350	Injection, mosunetuzumab-axgb, 1 mg
J9380	Injection, teclistamab-cqyv, 0.5 mg
J9381	Injection, teplizumab-mzwv, 5 mcg
Q4272	Esano a, per square centimeter
Q4273	Esano aaa, per square centimeter
Q4274	Esano ac, per square centimeter
Q4275	Esano aca, per square centimeter
Q4276	Orion, per square centimeter
Q4277	Woundplus membrane or e-graft, per square centimeter
Q4278	Epieffect, per square centimeter
Q4280	Xcell amnio matrix, per square centimeter
Q4281	Barrera sl or barrera dl, per square centimeter
Q4282	Cygnus dual, per square centimeter
Q4283	Biovance tri-layer or biovance 3l, per square centimeter
Q4284	Dermabind sl, per square centimeter
Q5131	Injection, adalimumab-aacf (idacio), biosimilar, 20 mg

Descriptions revised 3

Code	Was, and is now
G0460	~~Autologous platelet rich plasma for non-diabetic chronic wounds/ulcers, including phlebotomy, centrifugation, and all other preparatory procedures, administration and dressings, per treatment~~ Autologous platelet rich plasma or other blood-derived product for non-diabetic chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or mixing, and all other preparatory procedures, administration and dressings, per treatment
G0465	Autologous platelet rich plasma (prp) for diabetic chronic wounds/ulcers, using an fda-cleared device (includes administration, dressings, phlebotomy, centrifugation, and all other preparatory procedures, per treatment) Autologous platelet rich plasma (prp) or other blood-derived product for diabetic chronic wounds/ulcers, using an fda-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other preparatory procedures, per treatment)
J2426	~~Injection, paliperidone palmitate extended release, 1 mg~~ Injection, paliperidone palmitate extended release (invega sustenna), 1 mg

Terminated 9

Code	Description
C9146	Injection, mirvetuximab soravtansine-gynx, 1 mg
C9147	Injection, tremelimumab-actl, 1 mg
C9148	Injection, teclistamab-cqyv, 0.5 mg
C9149	Injection, teplizumab-mzwv, 5 mcg
J2370	Injection, phenylephrine hcl, up to 1 ml
S0020	Injection, bupivicaine hydrochloride, 30 ml
S0030	Injection, metronidazole, 500 mg
S0073	Injection, aztreonam, 500 mg
S0077	Injection, clindamycin phosphate, 300 mg